PELHAM MEDICAL PRACTICE — All Prescriptions & Medications — Page 12
Practice Code: G82032 | GRAVESEND, DA11 0HN
Showing results 551-600 of 638
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 16 | 180 | £403 | -63.6% ▼ | |
| 16 | 280 | £377 | +65.6% ▲ | |
| 16 | 660 | £1.4K | +13.1% ▲ | |
| Naloxegol | 15 | 450 | £787 | +8.8% ▲ |
| Bempedoic acid | 15 | 840 | £1.6K | -54.2% ▼ |
| Midazolam hydrochloride | 15 | 56 | £1.3K | +4.1% ▲ |
| Mebendazole | 15 | 311 | £18 | +31.0% ▲ |
| Biphasic insulin lispro | 15 | 85 | £527 | -65.1% ▼ |
| Cocois | 15 | 1,280 | £251 | +9.2% ▲ |
| Azelaic acid | 15 | 450 | £81 | -37.3% ▼ |
| Ketoconazole | 15 | 780 | £105 | +50.8% ▲ |
| 15 | 50 | £314 | -58.0% ▼ | |
| Glyceryl trinitrate | 14 | 420 | £523 | +5.4% ▲ |
| Torasemide | 14 | 392 | £133 | +24.7% ▲ |
| Levodopa/carbidopa/entacapone | 14 | 1,680 | £1.1K | -49.9% ▼ |
| Doxycycline monohydrate | 14 | 120 | £70 | +28.9% ▲ |
| Alogliptin/metformin | 14 | 1,568 | £708 | -66.4% ▼ |
| Betamethasone sodium phosphate | 14 | 474 | £64 | +13.9% ▲ |
| Estradiol valerate | 14 | 3,360 | £278 | -28.3% ▼ |
| Ready to serve 1 - 1.3 kcal/ml m/sk lower energy (0913011) | 14 | 94.0K | £1.3K | +100.9% ▲ |
| Ready to serve 2.4 kcal/ml milkshake lower volume (0913021) | 14 | 14.0K | £526 | +54.8% ▲ |
| Pyridostigmine bromide | 14 | 2,800 | £233 | -18.2% ▼ |
| Brinzolamide and timolol | 14 | 70 | £92 | -63.0% ▼ |
| Ipratropium bromide | 14 | 15 | £100 | -13.7% ▼ |
| 14 | 53 | £524 | +94.4% ▲ | |
| 14 | 420 | £780 | +9.4% ▲ | |
| 14 | 600 | £3.0K | +10.7% ▲ | |
| 14 | 800 | £453 | +91.6% ▲ | |
| 14 | 420 | £722 | -8.1% ▼ | |
| Lurasidone | 13 | 364 | £988 | -47.9% ▼ |
| Oxcarbazepine | 13 | 1,848 | £367 | -53.5% ▼ |
| Phenytoin | 13 | 19.5K | £158 | +18.4% ▲ |
| Itraconazole | 13 | 348 | £137 | -3.1% ▼ |
| Metformin hydrochloride/vildagliptin | 13 | 984 | £557 | -20.4% ▼ |
| Norethisterone | 13 | 2,212 | £53 | -7.0% ▼ |
| Powder 10g protein equivalent (0913226) | 13 | 690 | £4.0K | +12.5% ▲ |
| Sodium chloride | 13 | 53 | £604 | +96.4% ▲ |
| 13 | 261 | £920 | +96.1% ▲ | |
| 13 | 2,500 | £23 | -48.3% ▼ | |
| 13 | 650 | £532 | +135.5% ▲ | |
| 13 | 500 | £704 | +41.2% ▲ | |
| 13 | 360 | £2.5K | +2.5% ▲ | |
| Phosphates (Rectal) | 12 | 55 | £351 | -1.8% vs avg |
| Olmesartan medoxomil/hydrochlorothiazide | 12 | 672 | £399 | +21.0% ▲ |
| Frovatriptan | 12 | 114 | £301 | -15.1% ▼ |
| Soluble insulin (Neutral insulin) | 12 | 85 | £725 | +24.6% ▲ |
| Vardenafil | 12 | 92 | £174 | -14.1% ▼ |
| Exemestane | 12 | 490 | £110 | -63.1% ▼ |
| Degarelix | 12 | 12 | £1.4K | -30.9% ▼ |
| Oral rehydration salts | 12 | 106 | £44 | -58.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.